BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 33643890)

  • 1. Application of Radiomics Analysis Based on CT Combined With Machine Learning in Diagnostic of Pancreatic Neuroendocrine Tumors Patient's Pathological Grades.
    Zhang T; Zhang Y; Liu X; Xu H; Chen C; Zhou X; Liu Y; Ma X
    Front Oncol; 2020; 10():521831. PubMed ID: 33643890
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Application of CT-Based Radiomics in Discriminating Pancreatic Cystadenomas From Pancreatic Neuroendocrine Tumors Using Machine Learning Methods.
    Han X; Yang J; Luo J; Chen P; Zhang Z; Alu A; Xiao Y; Ma X
    Front Oncol; 2021; 11():606677. PubMed ID: 34367940
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A radiomics-based interpretable model to predict the pathological grade of pancreatic neuroendocrine tumors.
    Ye JY; Fang P; Peng ZP; Huang XT; Xie JZ; Yin XY
    Eur Radiol; 2024 Mar; 34(3):1994-2005. PubMed ID: 37658884
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Machine Learning Methods Based on CT Features Differentiate G1/G2 From G3 Pancreatic Neuroendocrine Tumors.
    Chen HY; Pan Y; Chen JY; Chen J; Liu LL; Yang YB; Li K; Ma Q; Shi L; Yu RS; Shao GL
    Acad Radiol; 2024 May; 31(5):1898-1905. PubMed ID: 38052672
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of radiomics based on
    Zhou Y; Ma XL; Zhang T; Wang J; Zhang T; Tian R
    Eur J Nucl Med Mol Imaging; 2021 Aug; 48(9):2904-2913. PubMed ID: 33547553
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CT-Based Radiomics Score for Distinguishing Between Grade 1 and Grade 2 Nonfunctioning Pancreatic Neuroendocrine Tumors.
    Bian Y; Jiang H; Ma C; Wang L; Zheng J; Jin G; Lu J
    AJR Am J Roentgenol; 2020 Oct; 215(4):852-863. PubMed ID: 32755201
    [No Abstract]   [Full Text] [Related]  

  • 7. Prediction of Pathological Grades of Pancreatic Neuroendocrine Tumors Based on Dynamic Contrast-Enhanced Ultrasound Quantitative Analysis.
    Yang DH; Cheng J; Tian XF; Zhang Q; Yu LY; Qiu YJ; Lu XY; Lou WH; Dong Y; Wang WP
    Diagnostics (Basel); 2023 Jan; 13(2):. PubMed ID: 36673048
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Radiomics Combined with Multiple Machine Learning Algorithms in Differentiating Pancreatic Ductal Adenocarcinoma from Pancreatic Neuroendocrine Tumor: More Hands Produce a Stronger Flame.
    Zhang T; Xiang Y; Wang H; Yun H; Liu Y; Wang X; Zhang H
    J Clin Med; 2022 Nov; 11(22):. PubMed ID: 36431266
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preoperative prediction for pathological grade of hepatocellular carcinoma via machine learning-based radiomics.
    Mao B; Zhang L; Ning P; Ding F; Wu F; Lu G; Geng Y; Ma J
    Eur Radiol; 2020 Dec; 30(12):6924-6932. PubMed ID: 32696256
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Diagnostic efficacy of a combined diagnostic model based on extreme gradient boosting algorithm in differentiating the pathological grading of gastric neuroendocrine neoplasms].
    Wang R; Liang P; Yu J; Han YJ; Gao JB
    Zhonghua Yi Xue Za Zhi; 2021 Sep; 101(34):2717-2722. PubMed ID: 34510879
    [No Abstract]   [Full Text] [Related]  

  • 11. CT-Radiomic Approach to Predict G1/2 Nonfunctional Pancreatic Neuroendocrine Tumor.
    Zhao Z; Bian Y; Jiang H; Fang X; Li J; Cao K; Ma C; Wang L; Zheng J; Yue X; Zhang H; Wang X; Madabhushi A; Xu J; Jin G; Lu J
    Acad Radiol; 2020 Dec; 27(12):e272-e281. PubMed ID: 32037260
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Textural analysis on contrast-enhanced CT in pancreatic neuroendocrine neoplasms: association with WHO grade.
    Guo C; Zhuge X; Wang Z; Wang Q; Sun K; Feng Z; Chen X
    Abdom Radiol (NY); 2019 Feb; 44(2):576-585. PubMed ID: 30182253
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Accurate non-invasive grading of nonfunctional pancreatic neuroendocrine tumors with a CT derived radiomics signature.
    Javed AA; Zhu Z; Kinny-Köster B; Habib JR; Kawamoto S; Hruban RH; Fishman EK; Wolfgang CL; He J; Chu LC
    Diagn Interv Imaging; 2024 Jan; 105(1):33-39. PubMed ID: 37598013
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preoperative Prediction of G1 and G2/3 Grades in Patients With Nonfunctional Pancreatic Neuroendocrine Tumors Using Multimodality Imaging.
    Liu C; Bian Y; Meng Y; Liu F; Cao K; Zhang H; Fang X; Li J; Yu J; Feng X; Ma C; Lu J; Xu J; Shao C
    Acad Radiol; 2022 Apr; 29(4):e49-e60. PubMed ID: 34175209
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Noncontrast Radiomics Approach for Predicting Grades of Nonfunctional Pancreatic Neuroendocrine Tumors.
    Bian Y; Zhao Z; Jiang H; Fang X; Li J; Cao K; Ma C; Guo S; Wang L; Jin G; Lu J; Xu J
    J Magn Reson Imaging; 2020 Oct; 52(4):1124-1136. PubMed ID: 32343872
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pancreatic neuroendocrine tumor: prediction of tumor grades by radiomics models based on ultrasound images.
    Dong Y; Yang DH; Tian XF; Lou WH; Wang HZ; Chen S; Qiu YJ; Wang W; Dietrich CF
    Br J Radiol; 2023 Sep; 96(1149):20220783. PubMed ID: 37393539
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Feasibility on the Use of Radiomics Features of 11[C]-MET PET/CT in Central Nervous System Tumours: Preliminary Results on Potential Grading Discrimination Using a Machine Learning Model.
    Russo G; Stefano A; Alongi P; Comelli A; Catalfamo B; Mantarro C; Longo C; Altieri R; Certo F; Cosentino S; Sabini MG; Richiusa S; Barbagallo GMV; Ippolito M
    Curr Oncol; 2021 Dec; 28(6):5318-5331. PubMed ID: 34940083
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Radiomics analysis for the differentiation of autoimmune pancreatitis and pancreatic ductal adenocarcinoma in
    Zhang Y; Cheng C; Liu Z; Wang L; Pan G; Sun G; Chang Y; Zuo C; Yang X
    Med Phys; 2019 Oct; 46(10):4520-4530. PubMed ID: 31348535
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prediction of the characteristics of aggressiveness of pancreatic neuroendocrine neoplasms (PanNENs) based on CT radiomic features.
    Mori M; Palumbo D; Muffatti F; Partelli S; Mushtaq J; Andreasi V; Prato F; Ubeira MG; Palazzo G; Falconi M; Fiorino C; De Cobelli F
    Eur Radiol; 2023 Jun; 33(6):4412-4421. PubMed ID: 36547673
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Application of low dose pancreas perfusion CT combined with enhancement scanning in diagnosis of pancreatic neuroendocrine tumors.
    Wan Y; Hao H; Meng S; Li Z; Yu F; Meng Chi ; Chao Q; Gao J
    Pancreatology; 2021 Jan; 21(1):240-245. PubMed ID: 33191144
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.